American science was well-organized during World War II. Today’s efforts to fight COVID-19 don’t come close to measuring up.
SLATE – Since January, researchers hoping to fight COVID-19 have designed a stunning 1,200 clinical trials, but the effort has been marked by disorder and disorganization, with huge financial resources wasted. Applying history lessons to today, the Department of Health Policy and Management’s Walid Gellad, director of the Center for Pharmaceutical Policy and Prescribing, slammed U.S. leadership for failing to set a clear clinical trial agenda.
Read the full story in Slate, adapted from 12 Seconds of Silence: How a Team of Inventors, Tinkerers, and Spies Took Down a Nazi Superweapon, by Jamie Holmes, published by Houghton Mifflin Harcourt.